INVESTORS IN MSK

Top Notch Healthcare.

Investment, Innovation and News

in Moravian-Silesian Healthcare

Even though we often hear complaints surrounding long waiting times at doctors’ offices

and comments regarding the poor state of our healthcare system, these assessments are

not entirely accurate. The Czech healthcare system is among the highest ranked in Europe.

According to an analysis of Czechia’s prosperity index, domestic healthcare ranks third in

the European Union. In comparison with other European countries, Czechia also boasts 5th

place in healthcare availability, a higher number of hospital beds, and even one of the strongest

cybersecurity protection systems worldwide. One facet where we are lacking, however, is

the health of Czech citizens themselves. One of the main culprits of this is an overall unhealthy

lifestyle, leading to high rates of obesity.

The Moravian-Silesian region is a perfect

example of the availability and quality of

healthcare in the Czech Republic. This

can be attributed to the region’s dense

web of hospitals and other medical

facilities, and constant investment

into the purchasing and upgrading of

equipment. In the past couple of years,

billions of crowns were invested not only

into regional hospitals, but to state and

private ones as well. The Faculty Hospital

of Ostrava received the largest share of

these investments. Annually, this hospital

receives around half a billion crowns

in investments. Last year, this money

was used to fund the construction of

a new pavilion focused on psychiatric

care, which ended up costing around

350 million crowns. Regional healthcare

facilities were not left behind either, as

innovations took place all over the region.

The Silesian hospital in Opava received

new insulation and further reconstruction

is planned for other pavilions. A new unit

focused on the treatment of persistent

vegetative states has been constructed

at the medical institution in Albrechtice

and new orthopedic surgical rooms will

be constructed at the hospital in Karviná.

New x-ray machines are being purchased

in Orlová and Bruntál, and the hospital in

Krnov will soon get to make use of a new

sciagraph. All of these are investments

worth dozens of million of crowns. Private

healthcare facilities are also seeing growth.

The Karviná Miners Hospital, for example,

has invested into constructing a new three

story building, purchased an MRI machine

and is planning further investment into

equipment and IT technologies.

Domestic as well as foreign pharmaceutical

and healthcare companies both have

strong presences in the Moravian-Silesian

region. One of the largest companies

in this category is Mölnlycke, a Swedish

company that operates two factories

in the region, producing surgical tools

and a variety of other products used in

treating wounds. The Israeli company

Teva is operating out of Opava, producing

generic medicine. Other influential

medicine producers in the region include

IMCoPharma or WALMARK. Start-ups

are also making a large contribution to

our healthcare system, and recently, they

have begun seeing great success within

our region. The company Invent Medical

is a perfect example of this. They focus

on order-made 3D printed prosthetic

and orthotic devices. Currently, they

also have partners in over 30 countries

around the world. This is by far not the

only innovative company in the rregion

and soon we will also be hearing from

companies such as H2 Global Group

(using hydrogen in medicine), Viderai

(detection of vision impairment), or

Madmonq (nutritional supplements).

www.positiv.cz ǀ 31